ADVERTISEMENT
 |
|
In This Issue
Build your biopharma development and manufacturing knowledge base with the latest whitepapers, application notes, posters, and other educational resources from biopharma industry suppliers.
|
|
|
|
Featured App Note
Jennifer S. Chadwick, Robert Garnick, Chen Li, Shiaw-Lin Wu, BioAnalytix
This whitepaper reviews fundamental aspects of host cell proteins (HCPs) that pertain to biologic drug development and presents current and emerging approaches to HCP analysis.
|
|
|
|
Formulation
 |
Unchained Labs
The critical process of screening formulation buffers to optimize stability is labor intensive and time consuming, which are often limiting factors in biologics development. The conformational, chemical, and colloidal stability of a protein are strongly influenced by the buffer solution. |
|
|
|
Analytical
 |
Shimadzu
Detection and quantification of peptides from transmembrane proteins is important for detection of biomarkers and new protein-based drugs. This paper presents a fully automated online digestion and liquid chromatography-mass spectrometry-multiple reaction monitoring (LC-MS/MRM) analysis of two model transmembrane proteins, a method that improves reproducibility and decreases chances of contamination. |
|
|
|
Downstream Processing
 |
Tosoh Bioscience LLC
In this application note, antibody drug conjugates (ADCs) were separated into groups with low, medium, and high drug-to-antibody ratios (DARs) using TOYOPEARL PPG-600M resin with a three-step gradient. |
|
Randy Drevland, Chelsea Pratt, Payal Khandelwal, Laura Moriarty, Elizabeth Jordan Dreskin, Bio-Rad
Remove the bottleneck of purifying therapeutic monoclonal antibodies (mAbs) for screening. Save time and increase productivity by automating multicolumn purification during drug development on the NGC Chromatography System. |
|
Ken Hoffman, Eric Bishop, Cygnus Technologies, LLC
Antibody affinity extraction (AAE) is a superior alternative to 2D Western blot for demonstrating host cell protein (HCP) antibody coverage and reactivity to those HCPs that persist through the downstream purification process. |
|
Bio-Rad
IgM antibodies are one of the fastest growing groups of diagnostic and therapeutic candidates. Unlike IgGs, IgMs cannot be purified by affinity chromatography due to their physiochemical properties. The large size of IgMs presents a purification challenge. A new AEX resin has been developed to overcome the multiple issues faced when purifying large biomolecules. |
|
|
|
|
|